The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Dentons

MARKGRAFENSTRASSE 33, 10117 BERLIN, GERMANY
Tel:
Work +49 30 264 73 0
Fax:
Fax +49 30 264 73 133
Email:
Web:
http://www.dentons.com

Show all Pressemitteilungen

SNR Denton Opening In Hong Kong

January 2011

NEW YORK, LONDON, January 4, 2011

The Board of SNR Denton Group (a Swiss Verein) announced today that it will add a new member firm in Hong Kong. The Hong Kong office, formerly affiliated with Hammonds LLP, will become associated with SNR Denton upon regulatory approval, and will include 20 professionals, including six partners. The office will initially be known as Brandt Chan & Partners.

"Since our combination, SNR Denton has executed a thoughtful and measured approach towards gaining additional scale in key regions, and today's announcement is evidence of that priority," said co-chief executive Elliott I. Portnoy. "With the addition of Hong Kong, we will be even better positioned to meet the ever growing cross-border needs of our clients. Our new colleagues have an unparalleled reputation in Hong Kong, and bring intimate knowledge of Chinese law, economics and culture," added Portnoy.

"Opening in Hong Kong allows us to broaden and deepen the resources and expertise available to our clients," added co-chief executive Howard Morris. "We are excited to add Hong Kong as it is a natural fit with our other locations in prominent business centers, such as New York and London, and offers our clients access to dynamic emerging economies."

SNR Denton currently has an office in Singapore. The opening of an office in Hong Kong is a step towards better serving China and north Asia. SNR Denton anticipates opening an office in mainland China in 2011.

The Hong Kong office offers clients high quality, experienced, dual qualified Hong Kong and English partners and Hong Kong and mainland Chinese lawyers. The office will be led by Keith Brandt, a dispute resolution partner, and Anthony Chan, a corporate and projects partner. Brandt and Chan bring with them a highly talented and experienced team: Valda Chan (China M&A and Investments), Jeffrey Cheung (Private Equity), Julianne Doe (Public Equity, Capital Markets and Securities) and Mary Thomson (Maritime, Insurance and Dispute Resolution).

"We see this as a fantastic time to join a growing global firm, and we are excited to both continue that growth for our new firm in Asia, while together further deepening our regional presence," said Brandt and Chan.

The core expertise of the office includes: domestic and international commercial dispute resolution and international arbitration; China inbound and outbound practice, mergers and acquisitions; construction and engineering; projects and project finance; energy and utilities; banking/trade and finance; private and public equity and securities; technology, media and telecommunications; and aviation/shipping. In addition, this office has within both Mandarin and Cantonese speaking lawyers specializing in a broad spectrum of China oriented work including retail, manufacturing, natural resources, construction and infrastructure, alternative energy, real estate, investment funds and private equity.


For more information please visit www.snrdenton.com

 

Co-Publishing von:
Dentons

  • Legal aspects of documenting shipping finance transactions in the United Arab Emirates

    The United Arab Emirates (UAE) is strategically placed between Europe and the Far East. The UAE has been ranked among the top 15 maritime nations by the United Nations Conference on Trade and Development and the UAE Government is working on plans to transform the shipping industry into one of the country’s major economic sectors.
    - SNR Denton

Co-Publishing weltweit

Rechtsentwicklungen und Neuigkeiten der führenden Anwälte in verschiedenen Jurisdiktionen. Für Beitrüge schicken Sie bitte eine Anfrage per Email an
  • China Drug Registration Regulation - Public consultation on amendment closes - March 2014

    In February 2014, the China Food and Drug Administration (“CFDA”) invited second-round comments from the public regarding proposed amendments to the China Drug Registration Regulations (“DRR”). One of the proposed amendments touches upon patent protection for drugs in China.
  • The Hong Kong Competition Ordinance - September 2014

    The Hong Kong Competition Ordinance was enacted by the Legislative Council in June 2012. You can download our briefing here .
  • Mobile payments: Change in your pocket with new opportunities - October 2014

    The mobile payments industry is developing rapidly. Increasingly integrated within the global economy, the ability to make mobile payments brings traditional players in the payments industry (such as financial institutions operating as merchant acquirers) together with retailers, mobile network operators (MNO) and other technology suppliers.
  • Revised NDRC Measures for Approval and Filing of Outbound Investment Projects - April 2014

    The National Development and Reform Commission ( NDRC ) released a new set of Management Measures for Approval and Filing of Outbound Investment Projects ( 境外投资项目核准和备案管理办法) ( New Measures ) on 8 April 2014. The New Measures take effect on 8 May 2014 and will replace the Interim Management Measures for Approval of Outbound Investment Projects ( 境外投资项目核准暂行管理办法) ( Original Measures ) which have been in force since 9 October 2004.
  • Insurance Update - CIRC Issues Insurance M&A Measures: What are the impacts and applications?

    On 21 March 2014, CIRC issued the Administrative Measures on the Acquisition and Merger of Insurance Companies (the Insurance M&A Measures ) which will take effect from 1 June 2014. The Insurance M&A Measures apply to M&A activities whereby an insurance company is the target for a merger or acquisition. The target insurance company could be either a domestic or a foreign invested insurer. However, the Insurance M&A Measures will not apply to any equity investment by insurance companies in non-insurance companies in China or in overseas insurance companies.
  • China issues new rules to regulate medical devices - May 2014

    The Regulations on Supervision and Administration of Medical Devices (in Chinese《医疗器械监督管理条例》, State Council Order No. 650) (the Medical Device Regulations) were amended by China's State Council on 31 March 2014 and will come into effect on 1 June 2014. This is the first amendment in more than a decade since the Medical Device Regulations were first promulgated in 2000, even though the amendment was initiated eight years ago in 2006. The 2014 amendment unveils reforms on the regulatory regime for medical devices market in China from various aspects.
  • Hong Kong: The evolving role of independent non-executive directors - May 2014

     In a recent speech given by Mr. Carlson Tong, Chairman of the Securities and Futures Commission, Mr. Tong pointed out that companies can improve corporate governance by attaching higher importance to the role of their board of directors as an internal gatekeeper. Mr. Tong said that this can be done more easily by having effective independent non-executive directors (INEDs) on the board.
  • Walking a fine line in China:Distinguishing between legitimate commercial deals and commercial bribe

    China in the 21st century exemplifies an atmosphere of great opportunity and intense competition. Against this backdrop, it has become increasingly common for businesses to adopt a variety of practices in order to make their products and services competitive. Such practices may include paying middle-men to promote sales and giving incentives to buyers directly. However, whilst revenue spikes are undoubtedly welcome, businesses should bear in mind the potential backlash arising out of these commercial arrangements. The risk that such arrangements may not comply with anti-bribery and corruption laws and therefore cause business significant damage in the long term should not be underestimated.
  • Competition law developments in East Asia - May 2014

    Authorities in Hong Kong have taken further steps in their deliberate approach to enforcing the Competition Ordinance. A little over a year after it was appointed, the Competition Commission released a report in which it provides a brief introduction to the Ordinance as well as a roadmap leading to its full entry into force. The report also explains how the Commission will prioritise its enforcement activities, and identifies the guidelines, policies and compliance tools which it plans to release before the Ordinance is enforced. Currently only some of the institutional provisions of the Ordinance are effective, allowing the Commission and the Competition Tribunal to prepare for enforcement.
  • Rise of the private healthcare sector - July 2014

    As of 2013, China had 9,800 private hospitals, representing almost half of the total number of hospitals in the country 1 . However, private hospitals still severely lag behind their public peers due to low utilisation, talent shortages and incomplete social insurance coverage. As part of China's ongoing healthcare reform initiatives, the Chinese government has set a goal to increase the share of patients treated by private hospitals to 20% by the end of 2015 2 .